Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
Siren Morken*, Seppo W Langer, Anna Sundlöv, Lene Weber Vestermark, Morten Ladekarl, Geir Olav Hjortland, Johanna B Svensson, Elizaveta Mitkina Tabaksblat, Torjan Magne Haslerud, Jörg Assmus, Sönke Detlefsen, Anne Couvelard, Aurel Perren, Halfdan Sorbye
*Corresponding author for this work
14
Citations
(Scopus)